Arthur Tzianabos, President & CEO at Homology Medicines, Inc. (FIXX), sold 25,000 shares at $16.25 ($404K) on 2019-12-02, disclosed to the SEC on 2019-12-03.
Open-market sale of $404k FIXX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.04 | 12,500 | $201K | 49.7% |
| 2 | $16.25 | 12,500 | $203K | 50.3% |
| Total | $16.14 avg | 25,000 | $404K | 100% |
| Filing → |
| FIXX | SELL | 2024-02-15 | $7K | — | Filing → |
| FIXX | SELL | 2023-01-11 | $15K | — | Filing → |
| FIXX | SELL | 2022-01-12 | $20K | — | Filing → |